Moxifloxacin
Moxifloxacin is a fluoroquinolone antibiotic available as oral tablets, intravenous infusion, and eye drops, used to treat a range of bacterial infections in adults — from pneumonia and skin infections to bacterial pink eye.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 25 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Moxifloxacin carries the FDA's most serious warning because it can cause disabling and potentially permanent side effects. These include tendinitis and tendon rupture (especially in the Achilles tendon at the back of the ankle), nerve damage in the arms and legs (peripheral neuropathy), and serious mental or nervous system effects like hallucinations, depression, anxiety, and seizures. These reactions can happen together, can start within hours of your first dose, and may not be fully reversible. Stop taking moxifloxacin and call your doctor right away if you notice any of these. Moxifloxacin can also worsen muscle weakness in people with myasthenia gravis — in some cases severely enough to require a breathing machine — so it should be avoided in those patients. Because of these risks, moxifloxacin should only be used for sinus infections and chronic bronchitis flare-ups when there is truly no safer alternative antibiotic available.
📖 Moxifloxacin: Patient Information Guide
A plain-language walkthrough of Moxifloxacin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Moxifloxacin is a fluoroquinolone antibiotic approved to treat several types of bacterial infections in adults, available in different forms for different uses:
- Oral tablets and IV injection: Community-acquired pneumonia
- Oral tablets and IV injection: Uncomplicated skin and skin structure infections
- Oral tablets and IV injection: Complicated skin and skin structure infections
- Oral tablets and IV injection: Complicated intra-abdominal infections (infections inside the belly)
- Oral tablets and IV injection: Plague
- Oral tablets and IV injection (use only when no alternative exists): Acute bacterial sinusitis
- Oral tablets and IV injection (use only when no alternative exists): Acute bacterial exacerbation of chronic bronchitis (sudden worsening of a chronic lung condition)
- Moxifloxacin ophthalmic solution (eye drops), including Vigamox: Bacterial conjunctivitis (pink eye) — for topical eye use only, not for body-wide infections
⚙️How it works▾
Moxifloxacin is a bactericidal antibiotic — meaning it actually kills bacteria rather than just stopping them from growing. It does this by blocking two enzymes bacteria rely on to copy and repair their DNA: DNA gyrase (topoisomerase II) and topoisomerase IV. Without these enzymes, the bacteria's genetic material becomes damaged and disorganized, and the bacteria die off.
Because it works through this unique mechanism, moxifloxacin is active against a wide range of bacteria, including some that are resistant to other types of antibiotics. Like all antibiotics, it should only be used for infections caused by bacteria it can actually target — not for viral infections like the flu or a cold.
💊How it's taken▾
Oral moxifloxacin tablets are taken once daily and can be taken with or without food — even a high-fat meal or yogurt does not reduce how well it's absorbed. If you take antacids, sucralfate, iron supplements, zinc, or multivitamins, take moxifloxacin at least 4 hours before or 8 hours after those products, as they can significantly reduce how much antibiotic gets into your system. The IV injection form is given once daily as a slow infusion over 60 minutes in a clinical setting and should never be given as a rapid injection; it should also not be mixed with other medications in the same IV bag or line. Moxifloxacin ophthalmic solution (eye drops) is used topically in the affected eye — one drop several times daily for 7 days depending on the specific product labeling. Always follow your prescriber's exact instructions and complete the full prescribed course even if you feel better earlier.
- Oral tablets: Once daily, with or without food; space away from antacids and mineral supplements
- IV infusion: Once daily over 60 minutes, given in a healthcare setting
- Eye drops: Instilled in the affected eye as directed (typically 2–3 times daily for 7 days depending on formulation)
🤒Side effects — in detail▾
The most common side effects with oral or IV moxifloxacin include:
- Nausea
- Diarrhea
- Headache
- Dizziness
- Vomiting
- Trouble sleeping (insomnia)
- Constipation
- Abdominal pain
More serious reactions — including tendon damage, nerve problems, severe allergic reactions, dangerous heart rhythm changes, and C. diff–related bowel infection — require stopping the medication and getting medical help right away. These are not common, but they are real risks with this class of antibiotic.
⚠️Warnings & precautions▾
- Tendon damage: Moxifloxacin can cause tendinitis (tendon inflammation) or tendon rupture — most often the Achilles tendon. Risk is highest in people over 60, those taking corticosteroids, and organ transplant recipients. Stop and seek care at the first sign of tendon pain or swelling.
- Nerve damage (peripheral neuropathy): Numbness, tingling, burning, or weakness in the arms or legs can develop quickly and may be irreversible. Stop the drug and call your doctor immediately if these occur.
- Central nervous system effects: Hallucinations, paranoia, depression, suicidal thoughts, confusion, seizures, and dizziness have been reported — sometimes after just the first dose.
- QT prolongation: Moxifloxacin can alter heart rhythm in a way that may trigger a dangerous arrhythmia. Avoid if you already have a prolonged QT interval, low potassium, or are on certain heart or psychiatric medications.
- Myasthenia gravis: Can severely worsen muscle weakness in people with this condition — avoid use entirely if you have myasthenia gravis.
- Severe allergic reactions: Anaphylaxis (life-threatening allergic reaction) can occur with the very first dose. Stop and seek emergency care if you develop hives, swelling, throat tightness, or difficulty breathing.
- C. diff–associated diarrhea: Like all antibiotics, moxifloxacin can disrupt gut bacteria and allow C. difficile to overgrow, causing severe, potentially life-threatening diarrhea. Report any significant diarrhea after starting antibiotics.
- Blood sugar changes: Both high and dangerously low blood sugar have been reported, especially in diabetic patients on insulin or sulfonylureas. Monitor blood glucose closely.
- Risk of aortic aneurysm: Epidemiologic data suggest a possible increased risk of aortic aneurysm (a dangerous ballooning of the aorta) within two months of use — particularly in older adults or those already at elevated risk.
🔀What it interacts with▾
Moxifloxacin has several meaningful interactions to be aware of:
- Antacids, sucralfate, iron, zinc, multivitamins: These bind to moxifloxacin in the gut and can dramatically reduce how much is absorbed. Take moxifloxacin at least 4 hours before or 8 hours after these products.
- Warfarin (blood thinner): Moxifloxacin can boost warfarin's blood-thinning effect, increasing bleeding risk. Close INR monitoring is needed.
- Class IA antiarrhythmics (quinidine, procainamide) and Class III antiarrhythmics (amiodarone, sotalol): These already affect heart rhythm; combining them with moxifloxacin significantly raises the risk of a dangerous arrhythmia. Avoid the combination.
- Other QT-prolonging drugs (certain antipsychotics, tricyclic antidepressants, erythromycin, cisapride): Additive risk of QT prolongation and arrhythmia — use with caution and discuss with your prescriber.
- Diabetes medications (insulin, sulfonylureas): Blood sugar disturbances — especially dangerous lows — are more likely when combined. Monitor blood glucose carefully.
- NSAIDs (ibuprofen, naproxen, etc.): Taking NSAIDs alongside fluoroquinolones may increase the risk of seizures.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy to quinolones: Do not take moxifloxacin if you've had a serious allergic reaction to moxifloxacin or any other quinolone antibiotic (e.g., ciprofloxacin, levofloxacin).
- Myasthenia gravis: Moxifloxacin is contraindicated — it can cause life-threatening muscle weakness worsening in people with this condition.
- History of tendon problems: Prior tendinitis or tendon rupture raises the risk further — discuss alternatives with your doctor.
- Heart conditions or QT-prolonging medications: Tell your doctor about any heart rhythm problems, low potassium, or medications that affect the QT interval before starting moxifloxacin.
- Older adults (60+): Higher risk of tendon damage and QT-related heart rhythm changes. Those taking corticosteroids are at especially elevated risk for tendon rupture.
- Pregnancy: Animal studies show potential fetal harm. There are no adequate human data. Discuss the risks and benefits with your provider.
- Breastfeeding: Moxifloxacin may pass into breast milk based on animal data. Weigh the benefits of breastfeeding against potential risk to the infant.
- Children under 18: Safety and effectiveness have not been established for systemic (oral or IV) use. Moxifloxacin also causes joint cartilage damage in young animals.
- Diabetes: Blood sugar can swing high or low — extra monitoring is needed if you're on insulin or oral diabetes drugs.
- Liver cirrhosis: Use with caution in patients with mild, moderate, or severe liver cirrhosis.
- High sodium diet or heart failure: The IV formulation contains a significant amount of sodium — those on sodium-restricted diets or with congestive heart failure should discuss this with their doctor.
🚑If you take too much▾
Single oral overdoses up to a large amount have been reported without serious events in some cases, but any suspected overdose should be treated with care. If an overdose happens, emptying the stomach, maintaining good hydration, and monitoring heart rhythm (EKG) are recommended steps. Activated charcoal given soon after an oral overdose may help reduce how much moxifloxacin the body absorbs.
📡Pharmacodynamics — effects in the body▾
Moxifloxacin kills bacteria by disrupting two enzymes essential to bacterial DNA function. Studies in healthy volunteers found that moxifloxacin does not appear to cause significant photosensitivity (skin sensitivity to sunlight) at standard doses — unlike some other fluoroquinolones. The drug can, however, prolong the QT interval on a heart tracing (EKG), a measurable electrical change in the heart that, in some circumstances, can increase the risk of serious arrhythmias (abnormal heart rhythms), particularly at higher concentrations or faster infusion rates.
🔬Pharmacokinetics — how your body processes it▾
Oral moxifloxacin tablets are very well absorbed — about 90% of the dose reaches the bloodstream, and food (even high-fat meals or yogurt) does not meaningfully change this. The drug has a half-life of roughly 12–16 hours with oral dosing, meaning it stays active in the body long enough to be effective with once-daily dosing. IV infusion delivers the drug more directly but results in similar overall drug exposure to the oral form. Moxifloxacin distributes widely throughout the body and does not require dose adjustments for kidney or liver impairment under standard prescribing guidelines.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F) .
📄 Written from Moxifloxacin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Moxifloxacin
155 supplements and herbal products have documented interactions with Moxifloxacin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 13
- Moderate · 121
- Minor · 21
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Moxifloxacin has been associated with lower levels of 11 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 10
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Moxifloxacin — the kind of thing our pharmacy team would talk through with you at the counter.
Can I eat or drink normally while taking moxifloxacin tablets? ▾
What side effects should I actually expect, and which ones should make me stop taking it? ▾
I've heard fluoroquinolones can damage tendons. Is that really a concern with moxifloxacin? ▾
I take warfarin for a blood clot. Is it safe to use moxifloxacin at the same time? ▾
Is moxifloxacin safe during pregnancy or while breastfeeding? ▾
Can my child take moxifloxacin tablets or the IV form? ▾
Is Moxifloxacin available over the counter? ▾
When was Moxifloxacin first available? ▾
Who makes Moxifloxacin? ▾
💬 Answers drafted from Moxifloxacin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Moxifloxacin comes
Moxifloxacin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
Eye drops
Injection
📊 Moxifloxacin across the U.S. market
How Moxifloxacin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (20) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Moxifloxacin is used
A general measure of how commonly Moxifloxacin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Moxifloxacin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Moxifloxacin prescribed? Of the 1,596 medications we measure, Moxifloxacin ranks #357 by Medicaid prescriptions — more than 78% of them.
Utilization by Moxifloxacin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
moxifloxacin 5 MG/ML Ophthalmic Solution Most dispensed
Summed across the 12 of 41 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 403818
moxifloxacin 400 MG Oral Tablet
Summed across the 3 of 67 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311787
250 ML moxifloxacin 1.6 MG/ML Injection
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 351156
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Moxifloxacin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 16 of 112 listed Moxifloxacin NDCs with Medicaid activity.
🔍 Compare Moxifloxacin products
A representative set of FDA-listed product records for Moxifloxacin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 5 mg/mL | Ophthalmic | A-S Medication Solutions × 6 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Advanced Rx Pharmacy of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Alcon Laboratories, Inc. | NDA | Find on DailyMed ↗ |
| 5 mg/mL | Ophthalmic | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Asclemed USA, Inc. | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Direct Rx × 6 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Fosun Pharma USA Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Gland Pharma Limited | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Harrow Eye, LLC | NDA | View NDC → |
| 5 mg/mL | Ophthalmic | Lifestar Pharma LLC | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Lupin Pharmaceuticals, Inc. × 4 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Mylan Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | NorthStar Rx LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Novartis Pharmaceuticals Corporation × 2 listings | NDA | View NDC → |
| 5 mg/mL | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Redpharm Drug × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | RPK Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Sandoz Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 5 mg/mL | Ophthalmic | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 5 mg/mL | Ophthalmic | Upsher-Smith Laboratories, LLC × 2 listings | ANDA | View NDC → |
| 💊Injection | ||||
| 400 mg/250 mL | Intravenous | Fresenius Kabi Norge AS | NDA | View NDC → |
| 400 mg/250 mL | Intravenous | Fresenius Kabi USA, LLC × 3 listings | NDA | View NDC → |
| 400 mg/250 mL | Intravenous | Hp Halden Pharma AS | NDA | View NDC → |
| 400 mg/250 mL | Intravenous | Mylan Institutional LLC × 2 listings | ANDA | View NDC → |
| 💊Tablet | ||||
| 400 mg | Oral | A-S Medication Solutions × 11 listings | ANDA | View NDC → |
| 400 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 400 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 400 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Breckenridge Pharmaceutical, Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 400 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 400 mg | Oral | Dr. Reddy's Laboratories Limited | ANDA | View NDC → |
| 400 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 400 mg | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Novel Laboratories, Inc. | ANDA | View NDC → |
| 400 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 11 listings | ANDA | View NDC → |
| 400 mg | Oral | RedPharm Drug, Inc. × 2 listings | ANDA | View NDC → |
| 400 mg | Oral | Remedyrepack Inc. × 4 listings | ANDA | View NDC → |
| 400 mg | Oral | Rising Health, LLC | ANDA | View NDC → |
| 400 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 400 mg | Oral | RPK Pharmaceuticals, Inc. | ANDA | View NDC → |
| 400 mg | Oral | Solaris Pharma Corporation | ANDA | View NDC → |
| 400 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 400 mg | Oral | Torrent Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 g/g | — | Almon Healthcare Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Anuh Pharma Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Aragen Life Sciences Limited | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Aurobindo Pharma Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Bayer AG | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Chongqing Huapont Shengchem Pharm. Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Chromo Laboratories India Private Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Darmerica, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dr. Reddy's Laboratories Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hetero Drugs Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hunan Jiudian Pharmaceutical Co.,Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Pharmachem Private Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | YiChang HEC ChangJiang Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 143 of 143 products — FDA National Drug Code Directory. See every product, package size and price: browse all 143 Moxifloxacin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Moxifloxacin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Moxifloxacin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Moxifloxacin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 139462 3 dose forms · 3 strengths
-
Dose form (SCDF) Injection RxCUI 1665194In current FDA listingsClinical drug / strength (SCD) 250 ML moxifloxacin 1.6 MG/MLRxCUI 351156 -
Dose form (SCDF) Ophthalmic Solution RxCUI 406106In current FDA listingsClinical drug / strength (SCD) 5 MG/MLRxCUI 403818 -
Dose form (SCDF) Oral Tablet RxCUI 374619In current FDA listingsClinical drug / strength (SCD) 400 MGRxCUI 311787
Look up RxCUI 139462 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Moxifloxacin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 25 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Camber Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.